Frequency of multi-resistant pathogens in rehabilitation medicine

Frequency of multi-resistant pathogens in rehabilitation medicine - HAMER study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009328

Enrollment

310

Registered

2015-09-23

Start date

2015-09-07

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50 I20

Interventions

Group 1: Patients with oncology or cardiac disease are examined once in multi-resistant pathogens. For this purpose, smear tests from the nose, mouth and a perianal swab will be taken. Moreover, urin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Rehabilitation patients with an oncology or cardiology disease irrespective of the third party-payers can participate in this study.

Exclusion criteria

Exclusion criteria: Rehabilitation patients without an oncology or cardiology disease.

Design outcomes

Primary

Measure	Time frame
Using a standardized questionnaire, biometric data, aspects of life, data about the rehab stay, morbidity and the course of therapy and pretreating of other medical establishments before the rehab stay are acquired. The oral questioning by the study staff will be lead immediately after the explanation of the study and the patient's consent to participate in the study.	—

Secondary

Measure	Time frame
Risk Factors for multiresistent pathogens	—

Countries

Germany

Contacts

Public ContactKarolin Heyne

Rehabilitationswissenschaften, Humanwissenschaftliche Fakultät, Universität Potsdam

karheyne@uni-potsdam.de0331 977-4063

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026